Product Reports Resources Pricing Login Book a demo
LP profile

Memorial Sloan Kettering

Other · Founded 1884 · New York City, United States

#108 LP Ranking #6 of 2,413 LPs
31 VC firms backed
$1.4B AUM
~$14M Allocated to VC (est. 1%)
01 · Background

Who Memorial Sloan Kettering is.

Historical Background
Memorial Sloan Kettering (MSK) was founded in 1884 as the New York Cancer Hospital, the first institution in the United States dedicated exclusively to cancer treatment. The modern entity was formed in 1980 through the merger of Memorial Hospital and the Sloan-Kettering Institute, which had been established in 1945 through a gift from Alfred P. Sloan and Charles F. Kettering.
Source of Capital
As a non-profit institution, MSK's capital is derived from a combination of patient care revenue, research grants, philanthropic donations, and returns from its investment portfolio. The investment office manages a substantial endowment to fund its research, clinical care, and educational missions.
Major Events
In 1980, Memorial Hospital for the Treatment of Cancer and Allied Diseases formally merged with the Sloan-Kettering Institute for Cancer Research to create the unified Memorial Sloan Kettering Cancer Center. In 2020, MSK opened the David H. Koch Center for Cancer Care, a 750,000-square-foot outpatient facility in Manhattan.
03 · Allocation

How Memorial Sloan Kettering’s fund book is spread.

The 31 funds Memorial Sloan Kettering backs, by where the manager is headquartered and how many funds that manager has raised.

Where those managers are based

By fund headquarters.

  • North America 2787%
  • Rest of world 310%
  • Europe 13%

United States 27 · China 2 · Hong Kong 1 · United Kingdom 1

How established those managers are

Managers grouped by how many funds they have raised — across the 25 of 31 with a fund history on record.

Emerging funds · 9
Established funds · 16
4 1
3 2
2 3
1 4
6 5-6
2 7-9
4 10-14
3 15+
Funds raised by the manager
04 · Direct investments

The companies Memorial Sloan Kettering backs directly.

Memorial Sloan Kettering holds 1 company directly, separate from the funds it commits to as a limited partner.

Nine Diagnostics
Health · USA
$320K valuation